Dentons advises Immunic on completion of one of the largest series A financing rounds in the European biotech sector

The Munich-based biotech company has won two new investors adding an additional €10 million in equity financing. The company’s series A financing round, with an overall investment size of €31.7 million, is now completed.

Windows
Windows
 
Redirection

You are switching to another language. Please click Confirm below to continue.

 
Important Notice